title: Atypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic study.
abstract: Objectives. The aim of this naturalistic study was to investigate whether treatment with clozapine and other atypical antipsychotics for at least 2 years was associated with a reduction in psychotic and depressive symptoms and an improvement in chronic schizophrenia patients' awareness of their illness. Methods. Twenty-three adult outpatients (15 men and 8 women) treated with clozapine and 23 patients (16 men and 7 women) treated with other atypical antipsychotics were included in the study. Psychotic symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS), depressive symptoms were assessed with the Calgary Depression Scale for Schizophrenia (CDSS), and insight was assessed with the Scale to Assess Unawareness of Mental Disorder (SUMD). Results. The sample as a whole had a significant reduction in positive, negative, and general symptoms, whereas the reduction in depression was significant only for patients with CDSS scores of 5 and higher at the baseline. At the follow-up, patients treated with other atypical antipsychotics reported a greater reduction in depression than patients treated with clozapine, but not when limiting the analyses to those with clinically relevant depression. Conclusions. Atypical antipsychotics may be effective in reducing psychotic and depressive symptoms and in improving insight in patients with chronic schizophrenia, with no differences in the profiles of efficacy between compounds.
authors: Division of Psychiatry, Department of Neurosciences, University of Parma, Via Volturno 39/E, I-43100 Parma, Italy.
authors: Marco
authors: M
authors: Innamorati
authors: Stefano
authors: S
authors: Baratta
authors: Cristina
authors: C
authors: Di Vittorio
authors: David
authors: D
authors: Lester
authors: Paolo
authors: P
authors: Girardi
authors: Maurizio
authors: M
authors: Pompili
authors: Mario
authors: M
authors: Amore
references: J Clin Pharm Ther. 2011 Apr;36(2):172-8
references: 21366646
references: Schizophr Res. 2008 Jul;102(1-3):1-18
references: 18514488
references: Schizophr Res. 2008 Feb;99(1-3):7-12
references: 18055177
references: Am J Med. 2007 Apr;120(4 Suppl 1):S26-31
references: 17403379
references: Encephale. 2004 Sep-Oct;30(5):474-91
references: 15627052
references: J Clin Psychiatry. 2004 Mar;65(3):312-21
references: 15096069
references: Schizophr Bull. 2008 Nov;34(6):1163-71
references: 18156640
references: Schizophr Res. 1990 Jul-Aug;3(4):247-51
references: 2278986
references: N Engl J Med. 2005 Sep 22;353(12):1209-23
references: 16172203
references: Clin Ther. 2004 May;26(5):649-66
references: 15220010
references: Drugs. 2004;64(15):1715-36
references: 15257633
references: Int J Psychiatry Med. 2011;41(3):245-51
references: 22073763
references: Biol Psychiatry. 1998 Jun 1;43(11):803-10
references: 9611669
references: Acta Psychiatr Scand Suppl. 2006;(429):46-50
references: 16445482
references: Schizophr Res. 2008 Jul;102(1-3):230-40
references: 18423985
references: Schizophr Res. 2001 Sep 1;51(2-3):171-80
references: 11518637
references: Arch Gen Psychiatry. 1980 Sep;37(9):979-83
references: 7416910
references: Lancet. 2009 Jan 3;373(9657):31-41
references: 19058842
references: Biol Psychiatry. 2010 Jul 1;68(1):86-92
references: 20227681
references: Neuropsychiatr Dis Treat. 2007 Apr;3(2):219-35
references: 19300555
references: Psychiatr Clin North Am. 2009 Dec;32(4):853-61
references: 19944888
references: Br J Psychiatry. 2006 Aug;189:102-8
references: 16880478
references: Schizophr Res. 2009 May;110(1-3):1-23
references: 19328655
references: Arch Gen Psychiatry. 2010 Dec;67(12):1230-7
references: 21135323
references: Am J Psychiatry. 1996 Aug;153(8):1001-8
references: 8678167
references: J Psychopharmacol. 2001 Jun;15(2):127-35
references: 11448086
references: Schizophr Res. 2008 Jan;98(1-3):201-8
references: 17919890
references: Clin Ther. 2008 Sep;30(9):1565-89
references: 18840365
references: Am J Psychiatry. 2000 Sep;157(9):1379-89
references: 10964850
references: Mol Psychiatry. 2005 Jan;10(1):79-104
references: 15289815
references: PLoS Med. 2005 May;2(5):e141
references: 15916472
references: Psychiatry Res. 1999 Jun 30;86(3):239-49
references: 10482343
references: J Clin Psychiatry. 2010 Jun;71(6):716-28
references: 20573330
references: J Nerv Ment Dis. 1977 Apr;164(4):231-46
references: 321725
references: Psychol Med. 1986 Nov;16(4):909-28
references: 3493497
references: Br J Hosp Med (Lond). 2011 Nov;72(11):628-30
references: 22083003
references: Schizophr Res. 2003 Jul 1;62(1-2):1-12
references: 12765737
references: Am J Health Syst Pharm. 2000 Feb 1;57(3):238-55
references: 10674777
references: J Clin Psychiatry. 2007 Feb;68(2):e04
references: 17335312
references: J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30
references: 10192404
references: Schizophr Res. 2011 Jun;129(1):1-11
references: 21530179
references: Arch Gen Psychiatry. 2005 Mar;62(3):247-53
references: 15753237
references: Drug Des Devel Ther. 2010 Feb 18;4:33-48
references: 20368905
references: Eur Psychiatry. 2012 Aug;27(6):401-5
references: 21570262
references: Schizophr Bull. 1989;15(1):81-9
references: 2717890
references: Ann Gen Psychiatry. 2007 Mar 16;6:10
references: 17367524
references: Schizophr Res. 1999 Jan 4;35(1):51-68
references: 9988841
references: Am J Psychiatry. 2003 Aug;160(8):1396-404
references: 12900300
references: J Neuropsychiatry Clin Neurosci. 1999 Fall;11(4):481-9
references: 10570762
references: Schizophr Res. 2009 Mar;108(1-3):223-30
references: 19070991
references: J Clin Pharm Ther. 2011 Dec;36(6):687-94
references: 21114507
references: Schizophr Res. 2007 Mar;91(1-3):254-8
references: 17293084
references: Arch Gen Psychiatry. 1998 Mar;55(3):250-8
references: 9510219
references: Suicide Life Threat Behav. 1992 Winter;22(4):479-93
references: 1488792
references: Psychiatry Res. 2004 Dec 15;129(2):141-7
references: 15590041
references: CNS Drugs. 2009 Oct;23(10):837-55
references: 19739694
references: BMC Psychiatry. 2011 Aug 26;11:143
references: 21871092
references: Schizophr Res. 2011 Sep;131(1-3):101-4
references: 21741216
references: Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1213-9
references: 15588748
references: Br J Psychiatry. 1984 Mar;144:303-6
references: 6704623
references: Psychiatry Res. 1988 Jan;23(1):99-110
references: 3363019
references: Eur Neuropsychopharmacol. 2007 Mar;17(4):235-44
references: 17137759
references: Schizophr Bull. 1990;16(4):571-89
references: 2077636
references: Prog Neuropsychopharmacol Biol Psychiatry. 2001 Nov;25(8):1481-95
references: 11642649
references: J Clin Psychiatry. 2005 Aug;66(8):1021-30
references: 16086618
references: CNS Drugs. 2009 Aug;23(8):649-59
references: 19594194
references: Schizophr Res. 2009 Nov;115(1):58-66
references: 19729283
references: Arch Gen Psychiatry. 1978 Oct;35(10):1181-5
references: 697536
references: Psychol Med Monogr Suppl. 1989;15:1-46
references: 2798648
references: BMJ. 2000 Dec 2;321(7273):1371-6
references: 11099280
references: J Clin Psychiatry. 2012 Apr;73(4):486-96
references: 22579147
references: Can J Psychiatry. 2010 Mar;55(3):117-25
references: 20370961
references: Psychol Med Monogr Suppl. 1992;20:1-97
references: 1565705